Risk Of Developing Liver Cancer After HCV Treatment

▼
Showing posts with label new hcv drugs. Show all posts
Showing posts with label new hcv drugs. Show all posts
Saturday, July 8, 2017

Debate - Do we need more HCV drugs?

›
18th International Workshop on Clinical Pharmacology of Antiviral Therapy 14 - 16 June 2017, Chicago, IL, USA The 18th edition of the meet...
Monday, January 2, 2017

2016/2017 - New HCV two and three drug regimens on their way: what do they promise?

›
Summary for AASLD 2016 for Hepatitis C - New HCV two and three drug regimens on their way: what do they promise? And what do clinicians need...
Tuesday, April 14, 2015

U.S. prescription drug spending rose 13 percent in 2014: IMS report

›
U.S. prescription drug spending rose 13 percent in 2014: IMS report By Bill Berkrot ( Reuters ) - U.S. spending on prescription medicine...
Monday, January 9, 2012

Hepatitis C-Presidio Phase 1a dose-ranging assessment of PPI-668 completed

›
SAN FRANCISCO -- (BUSINESS WIRE) -- Presidio Pharmaceuticals, Inc. announced today the successful completion of a Phase 1a dose-ranging ass...
Wednesday, January 4, 2012

New targets for antiviral therapy of chronic hepatitis C

›
New targets for antiviral therapy of chronic hepatitis C Liver International Download PDF (221K) Special Issue: Proceedings of the 5th...
Thursday, December 15, 2011

Watch-The Coming of Age of Direct Anti-Viral Agents for HCV

›
For many patients with Hepatitis C, direct anti-viral agents offer a potential cure. Marion Peters, MD discusses advances in this treatmen...
Tuesday, December 13, 2011

Market Update-The Quest For The Ideal Hepatitis C Therapy

›
The Hepatitis C Market: Biotech’s Version of the Daytona 500 Luke Timmerman 12/12/11 Biotech rivalries are sometimes a bit like boxing mat...
Tuesday, December 6, 2011

Hepatitis News Ticker-Boceprevir Case Study

›
Today @NATAP Boceprevir Case Study - Case Scenario A 52-year-old male executive who is asymptomatic is evaluated for abnormal liver bioc...